CollPlant Biotechnologies
CLGN
14 hedge funds and large institutions have $4.59M invested in CollPlant Biotechnologies in 2024 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 4 increasing their positions, 3 reducing their positions, and 1 closing their positions.
100% more first-time investments, than exits
New positions opened: 2 | Existing positions closed: 1
33% more repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 3
8% more funds holding
Funds holding: 13 → 14 (+1)
0.34% more ownership
Funds ownership: 10.78% → 11.12% (+0.34%)
32% less capital invested
Capital invested by funds: $6.79M → $4.59M (-$2.21M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PA
Pinnacle Associates
New York
|
+$87.8K |
| 2 |
AE
AMH Equity
Great Neck,
New York
|
+$70.3K |
| 3 |
Renaissance Technologies
New York
|
+$43.1K |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$41.7K |
| 5 |
Wells Fargo
San Francisco,
California
|
+$17.9K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BEI
Benjamin Edwards Inc
Clayton,
Missouri
|
-$112K |
| 2 |
SDJVC
St. Denis J. Villere & Co
New Orleans,
Louisiana
|
-$4.07K |
| 3 |
Bank of America
Charlotte,
North Carolina
|
-$1.32K |
| 4 |
Osaic Holdings
Scottsdale,
Arizona
|
-$732 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
PA
1
Pinnacle Associates
New York
| $1.76M | +$87.8K | +21,584 | +5% |
|
|
SDJVC
2
St. Denis J. Villere & Co
New Orleans,
Louisiana
| $1.74M | -$4.07K | -1,000 | -0.2% |
|
3
Brown Advisory
Baltimore,
Maryland
| $430K | – | – | – |
|
|
AE
4
AMH Equity
Great Neck,
New York
| $419K | +$70.3K | +17,295 | +17% |
|
|
5
UBS Group
Zurich,
Switzerland
| $79.9K | +$41.7K | +10,261 | +86% |
|
6
Pathstone Holdings
Englewood,
New Jersey
| $61.2K | – | – | – |
|
|
7
Renaissance Technologies
New York
| $38.2K | +$43.1K | +10,600 | New |
|
|
8
Wells Fargo
San Francisco,
California
| $30.3K | +$17.9K | +4,405 | +110% |
|
|
PA
9
Parallel Advisors
San Francisco,
California
| $11.7K | – | – | – |
|
|
10
Bank of America
Charlotte,
North Carolina
| $9K | -$1.32K | -325 | -12% |
|
11
National Bank of Canada
Montreal,
Quebec, Canada
| $900 | – | – | – |
|
|
SS
12
SBI Securities
Tokyo,
Japan
| $720 | +$813 | +200 | New |
|
|
13
Osaic Holdings
Scottsdale,
Arizona
| $684 | -$732 | -180 | -49% |
|
14
Morgan Stanley
New York
| $6 | – | – | – |
|
|
BEI
15
Benjamin Edwards Inc
Clayton,
Missouri
| – | -$112K | -23,810 | Closed |
|
CLGN Hedge Fund Activity: Q4 2024 in Review
14 of the 7,592 institutional investors tracked by Wall St. Rank reported a position in CollPlant Biotechnologies (CLGN) for Q4 2024, worth a combined $4.59M — down 32% from $6.79M a quarter earlier.
Buyers outnumbered sellers: 2 funds opened new CLGN positions and 1 closed out — a net gain of 1 holder — while 4 added to existing stakes and 3 trimmed.
The largest buyer was Pinnacle Associates, adding an estimated $87.8K. The largest seller was Benjamin Edwards Inc, exiting entirely with an estimated $112K sold.
- 14 institutional investors held CollPlant Biotechnologies (CLGN) as of Q4 2024, up from 13 in Q3 2024.
- Funds reported $4.59M of CollPlant Biotechnologies stock for Q4 2024, down 32% quarter-over-quarter.
- 2 funds opened new CollPlant Biotechnologies positions in Q4 2024 and 1 closed out, a net change of +1 holder.
- The largest CollPlant Biotechnologies buyer in Q4 2024 was Pinnacle Associates, an estimated $87.8K added.
- The largest CollPlant Biotechnologies seller in Q4 2024 was Benjamin Edwards Inc, an estimated $112K sold.
Based on aggregated 13F filings for Q4 2024.